메뉴 건너뛰기




Volumn 21, Issue 1, 2018, Pages 1-3

Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy

Author keywords

[No Author keywords available]

Indexed keywords


EID: 85048561079     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/eb-2017-102827     Document Type: Article
Times cited : (25)

References (7)
  • 1
    • 0037051872 scopus 로고    scopus 로고
    • Placebo response in studies of major depression: Variable, substantial, and growing
    • Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002;287:1840-7.
    • (2002) JAMA , vol.287 , pp. 1840-1847
    • Walsh, B.T.1    Seidman, S.N.2    Sysko, R.3
  • 2
    • 57049188862 scopus 로고    scopus 로고
    • Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
    • Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol 2009;19:34-40.
    • (2009) Eur Neuropsychopharmacol , vol.19 , pp. 34-40
    • Papakostas, G.I.1    Fava, M.2
  • 3
    • 38349049478 scopus 로고    scopus 로고
    • Selective publication of antidepressant trials and its influence on apparent efficacy
    • Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60.
    • (2008) N Engl J Med , vol.358 , pp. 252-260
    • Turner, E.H.1    Matthews, A.M.2    Linardatos, E.3
  • 4
    • 84992183988 scopus 로고    scopus 로고
    • Placebo response rates in antidepressant trials: A systematic review of published and unpublished double-blind randomised controlled studies
    • Furukawa TA, Cipriani A, Atkinson LZ, et al. Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry 2016;3:1059-66.
    • (2016) Lancet Psychiatry , vol.3 , pp. 1059-1066
    • Furukawa, T.A.1    Cipriani, A.2    Atkinson, L.Z.3
  • 5
    • 85019224711 scopus 로고    scopus 로고
    • Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013
    • Khan A, Fahl Mar K, Faucett J, et al. Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013. World Psychiatry 2017;16:181-92.
    • (2017) World Psychiatry , vol.16 , pp. 181-192
    • Khan, A.1    Fahl Mar, K.2    Faucett, J.3
  • 6
    • 84878252449 scopus 로고    scopus 로고
    • Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis
    • Spineli LM, Higgins JP, Cipriani A, et al. Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis. Clin Trials 2013;10:378-88.
    • (2013) Clin Trials , vol.10 , pp. 378-388
    • Spineli, L.M.1    Higgins, J.P.2    Cipriani, A.3
  • 7
    • 84978505054 scopus 로고    scopus 로고
    • Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: Protocol for a network meta-analysis
    • Furukawa TA, Salanti G, Atkinson LZ, et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open 2016;6:e010919.
    • (2016) BMJ Open , vol.6 , pp. e010919
    • Furukawa, T.A.1    Salanti, G.2    Atkinson, L.Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.